US Stock MarketDetailed Quotes
RPHM Reneo Pharmaceuticals
- 1.420
- -0.010-0.70%
Close Sep 10 16:00 ET
- 1.420
- 0.0000.00%
Post 16:12 ET
47.47MMarket Cap-845P/E (TTM)
1.500High1.420Low55.01KVolume1.430Open1.430Pre Close78.77KTurnover0.64%Turnover RatioLossP/E (Static)33.43MShares9.21052wk High0.62P/B12.14MFloat Cap0.98052wk Low--Dividend TTM8.55MShs Float17.180Historical High--Div YieldTTM5.59%Amplitude0.980Historical Low1.432Avg Price1Lot Size
Reneo Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -69.75%6.36M | -40.68%9.56M | 54.24%83.05M | 71.72%25.01M | 50.92%20.89M | 69.25%21.04M | 23.88%16.12M | 35.24%53.85M | 37.07%14.56M | 8.53%13.84M |
| Selling and administrative expenses | -13.03%5.77M | -9.94%4.62M | 63.79%26.44M | 76.03%7.4M | 86.21%7.27M | 54.43%6.64M | 37.33%5.13M | 38.58%16.14M | 19.32%4.21M | 13.63%3.9M |
| -General and administrative expense | -13.03%5.77M | -9.94%4.62M | 63.79%26.44M | 76.03%7.4M | 86.21%7.27M | 54.43%6.64M | 37.33%5.13M | 38.58%16.14M | 19.32%4.21M | 13.63%3.9M |
| Research and development costs | -95.90%590K | -55.04%4.94M | 50.15%56.61M | 69.97%17.6M | 37.07%13.62M | 77.08%14.4M | 18.46%10.99M | 33.85%37.71M | 45.87%10.36M | 6.65%9.94M |
| Operating profit | 69.75%-6.36M | 40.68%-9.56M | -54.24%-83.05M | -71.72%-25.01M | -50.92%-20.89M | -69.25%-21.04M | -23.88%-16.12M | -35.24%-53.85M | -37.07%-14.56M | -8.53%-13.84M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | -33.49%1M | 12.01%1.14M | 199.26%5.67M | 50.94%1.45M | 103.12%1.69M | 1,167.23%1.51M | 4,938.10%1.02M | 3,843.75%1.89M | 5,558.82%962K | 4,800.00%833K |
| Other non- operating income (expenses) | -33.49%1M | 12.01%1.14M | 199.26%5.67M | 50.94%1.45M | 103.12%1.69M | 1,167.23%1.51M | 4,938.10%1.02M | 3,843.75%1.89M | 5,558.82%962K | 4,800.00%833K |
| Income before tax | 72.55%-5.36M | 44.22%-8.43M | -48.95%-77.39M | -73.19%-23.55M | -47.58%-19.2M | -58.63%-19.53M | -15.89%-15.11M | -30.64%-51.96M | -28.22%-13.6M | -2.14%-13.01M |
| Income tax | ||||||||||
| Net income | 72.55%-5.36M | 44.22%-8.43M | -48.95%-77.39M | -73.19%-23.55M | -47.58%-19.2M | -58.63%-19.53M | -15.89%-15.11M | -30.64%-51.96M | -28.22%-13.6M | -2.14%-13.01M |
| Net income continuous Operations | 72.55%-5.36M | 44.22%-8.43M | -48.95%-77.39M | -73.19%-23.55M | -47.58%-19.2M | -58.63%-19.53M | -15.89%-15.11M | -30.64%-51.96M | -28.22%-13.6M | -2.14%-13.01M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 72.55%-5.36M | 44.22%-8.43M | -48.95%-77.39M | -73.19%-23.55M | -47.58%-19.2M | -58.63%-19.53M | -15.89%-15.11M | -30.64%-51.96M | -28.22%-13.6M | -2.14%-13.01M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 72.55%-5.36M | 44.22%-8.43M | -48.95%-77.39M | -73.19%-23.55M | -47.58%-19.2M | -58.63%-19.53M | -15.89%-15.11M | -30.64%-51.96M | -28.22%-13.6M | -2.14%-13.01M |
| Basic earnings per share | 75.38%-0.16 | 58.33%-0.25 | -18.87%-2.52 | -26.79%-0.71 | -7.55%-0.57 | -30.00%-0.65 | -13.21%-0.6 | 3.20%-2.12 | -30.23%-0.56 | -1.92%-0.53 |
| Diluted earnings per share | 75.38%-0.16 | 58.33%-0.25 | -18.87%-2.52 | -26.79%-0.71 | -7.55%-0.57 | -30.00%-0.65 | -13.21%-0.6 | 3.20%-2.12 | -30.23%-0.56 | -1.92%-0.53 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg